Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1971
DOI: 10.1016/0009-8981(71)90336-6
|View full text |Cite
|
Sign up to set email alerts
|

Identification of dangerous drugs by mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
15
0
1

Year Published

1973
1973
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(16 citation statements)
references
References 6 publications
0
15
0
1
Order By: Relevance
“…A technique has been developed which combines the high resolving power of GC and the sensitivity and specific ion-detecting ability of the mass spectrometer, thus simplifying considerably the problems encountered previously with mass spectral analysis. GC-mass spectrometry has found wide application in the qualitative identification of drugs (189), especially where small quantities of drugs and metabolites may be involved. The use of stable isotopes in clinical pharmacology, particularly as tracers for drug distribution and metabolism studies, were reviewed (32).…”
Section: Methods-stablementioning
confidence: 99%
“…A technique has been developed which combines the high resolving power of GC and the sensitivity and specific ion-detecting ability of the mass spectrometer, thus simplifying considerably the problems encountered previously with mass spectral analysis. GC-mass spectrometry has found wide application in the qualitative identification of drugs (189), especially where small quantities of drugs and metabolites may be involved. The use of stable isotopes in clinical pharmacology, particularly as tracers for drug distribution and metabolism studies, were reviewed (32).…”
Section: Methods-stablementioning
confidence: 99%
“…In fact, when MS was first adopted by clinical laboratorians in the early 1970s, it was only an investigative tool for metabolic profiling in urine [ [5] , [6] , [7] , [8] ] and other body fluids [ [9] , [10] , [11] ]. The first clinical laboratory applications of MS were toxicology assays targeting therapeutic drugs, drugs of abuse and their metabolites [ [12] , [13] , [14] , [15] , [16] , [17] ]. With the rapid development of immunoassays in the 1970 to 1980s, first with radioactive labelling [ [18] , [19] , [20] ], then with enzymes [ 21 ] and fluorophores [ 22 ]; and the paradigm shift from phenotyping towards genotyping in the 1990s, largely facilitated by PCR [ 23 ], automated DNA sequencing technologies [ 24 ] and human and microbial genome projects [ 25 , 26 ], the many virtues of MS-based techniques were outshone.…”
Section: Introductionmentioning
confidence: 99%
“…[*] Die Bedeutung der GC/MS fur dieses Gebiet war klar erkannt[86], jedoch arheiteten die bereits verfugbaren Gerate relativ langsam und waren im allgemeinen fur Nichtroutineprobleme reserviert[87]. [**] DieGegenwart mehrerer[MH] +-ion en,^.…”
unclassified